A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has improved symptoms and quality of life for the majority of patients.
20 November 2018A collaborative research project aimed at discovering a drug to treat a highly resistant form of breast cancer is one of two projects given the green light by the Queensland Emory Development (QED) Alliance.
7 November 2013
